This country profile provides an overview of Gambia’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
33k people received treatment in Gambia in 2019 135k people did not receive treatment in Gambia in 2019
Gambia does not require mass treatment for elephantiasis.
Gambia claims to have eliminated blinding trachoma as a public health problem.
Treatment coverage decreased from 48% in 2018 to 47% in 2019.
Pre-sch and school-aged children needing treatment71k
Pre-school and school-aged children receiving treatment33k
Treatment coverage decreased from 61% in 2018 to 0% in 2019.
School-aged children needing treatment98k
School-aged children receiving treatmentZero
Gambia does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Gambia.